{"id":58459,"date":"2026-06-04T22:04:32","date_gmt":"2026-06-04T13:04:32","guid":{"rendered":"https:\/\/japanir.jp\/en\/company\/company-4978\/"},"modified":"2026-08-16T14:02:10","modified_gmt":"2026-08-16T05:02:10","slug":"company-4978","status":"publish","type":"company","link":"https:\/\/japanir.jp\/en\/company\/company-4978\/","title":{"rendered":"REPROCELL INCORPORATED"},"content":{"rendered":"","protected":false},"featured_media":0,"template":"","meta":{"Ticker":"4978","DATE":"2026-01-09","longName":"ReproCELL Incorporated","company_name_ja":"","fullTimeEmployees":101,"address":"","phone":"","website":"https:\/\/www.reprocell.com","industry":"Biotechnology","sector":"Healthcare","regularMarketPrice":149,"financialCurrency":"","marketCap":14108,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":-6.25,"epsForward":0,"bookValue":0,"totalRevenue":2233518000,"OperatingIncome":-860064000,"operatingMargins":-38.509999999999998,"NetIncome":-591693000,"profitMargins":-26.489999999999998,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":-7.1200000000000001,"recommendationMean":0,"recommendationKey":"none","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"{\"success\": true, \"fetched_at\": \"2026-08-01T04:08:14.608165\", \"ticker\": \"4978\", \"ticker_full\": \"4978.T\", \"company_name\": \"REPROCELL INCORPORATED\", \"analyst_recommendations\": {\"has_data\": true, \"recommendation_key\": \"none\", \"recommendation_mean\": null, \"total_analysts\": null, \"strong_buy\": null, \"buy\": null, \"hold\": null, \"sell\": null, \"strong_sell\": null}, \"target_prices\": {\"has_data\": true, \"current\": 127.0, \"high\": null, \"low\": null, \"mean\": null, \"median\": null}, \"earnings_dates\": {\"has_data\": true, \"next_earnings\": null, \"future_count\": 0, \"past_earnings\": [{\"date\": \"2025-02-12\", \"eps_estimate\": -0.34, \"eps_actual\": 0.8, \"surprise_pct\": 335.29}, {\"date\": \"2024-08-12\", \"eps_estimate\": 1.57, \"eps_actual\": -0.84, \"surprise_pct\": -153.5}, {\"date\": \"2024-05-12\", \"eps_estimate\": -3.62, \"eps_actual\": -0.94, \"surprise_pct\": 74.03}, {\"date\": \"2024-02-08\", \"eps_estimate\": -0.94, \"eps_actual\": -0.14, \"surprise_pct\": 85.11}, {\"date\": \"2023-11-09\", \"eps_estimate\": -2.14, \"eps_actual\": -0.14, \"surprise_pct\": 93.46}]}, \"shareholders\": {\"has_data\": true, \"insider_pct\": 4.54, \"institution_pct\": 1.98, \"major_holders\": [{\"label\": \"\", \"value\": 4.54}, {\"label\": \"\", \"value\": 1.98}, {\"label\": \"\", \"value\": 2.07}, {\"label\": \"\", \"value\": 5.0}], \"institutional_holders\": [{\"holder\": \"SPDR INDEX SHARES FUNDS-SPDR Portfolio Developed World ex-US ETF\", \"shares\": 659600, \"date_reported\": \"2025-06-30\", \"pct_held\": 0.7, \"pct_change\": -0.27, \"value\": 83769200}, {\"holder\": \"DFA INVESTMENT TRUST CO-The Japanese Small Company Series\", \"shares\": 53000, \"date_reported\": \"2025-04-30\", \"pct_held\": 0.06, \"pct_change\": 0.0, \"value\": 6731000}, {\"holder\": \"SPDR INDEX SHARES FUNDS-SPDR(R) S&P(R) International Small Cap ETF\", \"shares\": 40800, \"date_reported\": \"2025-06-30\", \"pct_held\": 0.04, \"pct_change\": -1.45, \"value\": 5181600}, {\"holder\": \"American Century ETF Trust-Avantis International Small Cap Equity ETF\", \"shares\": 7800, \"date_reported\": \"2025-06-30\", \"pct_held\": 0.01, \"pct_change\": 0.0, \"value\": 990600}], \"mutualfund_holders\": []}}","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"ReproCELL Incorporated provides stem cell research and drug discovery services in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, pluripotent stem cells, StemEdit gene edited iPSCs, mesenchymal stem cells (MSCs), and new immortalized cell lines and related reagents; and iPSC-derived exosomes. The company also provides Alvetex 3D, a cell culture system; Alvetex, an advanced tissue bioengineering system; EZSPHERE Multiwell Dishes and Plates; KOKEN atelocollagen; ABLE Biott bioreactor systems; and 2mag stirrer systems. In addition, It offers research stem cell, genomics, clinical stem cell research, preclinical and drug discovery CRO, precision medicine, human tissue samples, clinical laboratory, and gene editing services. ReproCELL Incorporated was incorporated in 2003 and is based in Yokohama, Japan.","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"financial_data":"","detailed_financial_data":"{\"success\": true, \"fetched_at\": \"2026-08-16T02:12:08.078064\", \"ticker\": \"4978\", \"ticker_full\": \"4978.T\", \"company_name\": \"REPROCELL INCORPORATED\", \"company_info\": {\"name_en\": \"REPROCELL INCORPORATED\", \"long_name\": \"ReproCELL Incorporated\", \"sector\": \"Healthcare\", \"industry\": \"Biotechnology\", \"website\": \"https:\/\/www.reprocell.com\", \"employees\": 101, \"country\": \"Japan\", \"city\": \"Yokohama\", \"address\": \"MetLife Shin-Yokohama Building\", \"description\": \"ReproCELL Incorporated provides stem cell research and drug discovery services in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, pluripotent stem cells, StemEdit gene edited iPSCs, mesenchymal stem cells (MSCs), and new immortalized cell lines and related reagents; and iPSC-derived exosomes. The company also provides Alvetex 3D, a cell culture system; Alvetex, an advanced tissue bioengineering system; EZSPHERE Multiwell Dishes and Plates; KOKEN atelocollagen; ABLE Biott bioreactor systems; and 2mag stirrer systems. In addition, It offers research stem cell, genomics, clinical stem cell research, preclinical and drug discovery CRO, precision medicine, human tissue samples, clinical laboratory, and gene editing services. ReproCELL Incorporated was incorporated in 2003 and is based in Yokohama, Japan.\"}, \"price_trend\": {\"ma_5\": {\"ma_value\": 139.6, \"deviation\": 6.02, \"trend\": \"up\"}, \"ma_25\": {\"ma_value\": 129.36, \"deviation\": 14.41, \"trend\": \"up\"}, \"ma_75\": {\"ma_value\": 136.45, \"deviation\": 8.46, \"trend\": \"up\"}, \"ma_200\": {\"ma_value\": 155.25, \"deviation\": -4.67, \"trend\": \"down\"}}, \"financials\": {\"years\": [{\"year\": 2026, \"revenue\": 2233518000.0, \"revenue_fmt\": \"\u00a522\u5104\", \"gross_profit\": 1015356000.0, \"gross_profit_fmt\": \"\u00a510\u5104\", \"operating_income\": -860064000.0, \"operating_income_fmt\": \"-\u00a59\u5104\", \"ebit\": -860064000.0, \"ebit_fmt\": \"-\u00a59\u5104\", \"net_income\": -591693000.0, \"net_income_fmt\": \"-\u00a56\u5104\", \"eps\": -6.25, \"operating_margin\": -38.51, \"total_assets\": 9052627000.0, \"total_assets_fmt\": \"\u00a591\u5104\", \"total_equity\": 8311593000.0, \"total_equity_fmt\": \"\u00a583\u5104\", \"total_debt\": 0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 2939057000.0, \"total_cash_fmt\": \"\u00a529\u5104\", \"equity_ratio\": 91.81, \"de_ratio\": 0.0, \"current_ratio\": 10.91, \"operating_cf\": -383526000.0, \"operating_cf_fmt\": \"-\u00a54\u5104\", \"investing_cf\": 57940000.0, \"investing_cf_fmt\": \"\u00a557.9M\", \"financing_cf\": 0, \"financing_cf_fmt\": \"N\/A\", \"free_cf\": -481748000.0, \"free_cf_fmt\": \"-\u00a55\u5104\", \"net_margin\": -26.49, \"roe\": -7.12, \"roa\": -6.54}, {\"year\": 2025, \"revenue\": 2978627000.0, \"revenue_fmt\": \"\u00a530\u5104\", \"gross_profit\": 1649085000.0, \"gross_profit_fmt\": \"\u00a516\u5104\", \"operating_income\": -130410000.0, \"operating_income_fmt\": \"-\u00a51\u5104\", \"ebit\": -130410000.0, \"ebit_fmt\": \"-\u00a51\u5104\", \"net_income\": 103245000.0, \"net_income_fmt\": \"\u00a51\u5104\", \"eps\": 1.11, \"operating_margin\": -4.38, \"total_assets\": 9670755000.0, \"total_assets_fmt\": \"\u00a597\u5104\", \"total_equity\": 8984946000.0, \"total_equity_fmt\": \"\u00a590\u5104\", \"total_debt\": 0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 2823367000.0, \"total_cash_fmt\": \"\u00a528\u5104\", \"equity_ratio\": 92.91, \"de_ratio\": 0.0, \"current_ratio\": 7.64, \"operating_cf\": 6287000.0, \"operating_cf_fmt\": \"\u00a56.3M\", \"investing_cf\": -795995000.0, \"investing_cf_fmt\": \"-\u00a58\u5104\", \"financing_cf\": 680110000.0, \"financing_cf_fmt\": \"\u00a57\u5104\", \"free_cf\": -89857000.0, \"free_cf_fmt\": \"-\u00a589.9M\", \"net_margin\": 3.47, \"roe\": 1.15, \"roa\": 1.07}, {\"year\": 2024, \"revenue\": 2426817000.0, \"revenue_fmt\": \"\u00a524\u5104\", \"gross_profit\": 1120972000.0, \"gross_profit_fmt\": \"\u00a511\u5104\", \"operating_income\": -409293000.0, \"operating_income_fmt\": \"-\u00a54\u5104\", \"ebit\": -409293000.0, \"ebit_fmt\": \"-\u00a54\u5104\", \"net_income\": -31415000.0, \"net_income_fmt\": \"-\u00a531.4M\", \"eps\": -0.37, \"operating_margin\": -16.87, \"total_assets\": 9052627000.0, \"total_assets_fmt\": \"\u00a591\u5104\", \"total_equity\": 8311593000.0, \"total_equity_fmt\": \"\u00a583\u5104\", \"total_debt\": 0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 2939057000.0, \"total_cash_fmt\": \"\u00a529\u5104\", \"equity_ratio\": 91.81, \"de_ratio\": 0.0, \"current_ratio\": 10.91, \"operating_cf\": -11451000.0, \"operating_cf_fmt\": \"-\u00a511.5M\", \"investing_cf\": 404424000.0, \"investing_cf_fmt\": \"\u00a54\u5104\", \"financing_cf\": 544050000.0, \"financing_cf_fmt\": \"\u00a55\u5104\", \"free_cf\": -203884000.0, \"free_cf_fmt\": \"-\u00a52\u5104\", \"net_margin\": -1.29, \"roe\": -0.38, \"roa\": -0.35}, {\"year\": 2023, \"revenue\": 2953271000.0, \"revenue_fmt\": \"\u00a530\u5104\", \"gross_profit\": 1141247000.0, \"gross_profit_fmt\": \"\u00a511\u5104\", \"operating_income\": -356224000.0, \"operating_income_fmt\": \"-\u00a54\u5104\", \"ebit\": -303582000.0, \"ebit_fmt\": \"-\u00a53\u5104\", \"net_income\": -305313000.0, \"net_income_fmt\": \"-\u00a53\u5104\", \"eps\": -3.62, \"operating_margin\": -12.06, \"total_assets\": 8355848000.0, \"total_assets_fmt\": \"\u00a584\u5104\", \"total_equity\": 7575223000.0, \"total_equity_fmt\": \"\u00a576\u5104\", \"total_debt\": 0, \"total_debt_fmt\": \"N\/A\", \"total_cash\": 1914569000.0, \"total_cash_fmt\": \"\u00a519\u5104\", \"equity_ratio\": 90.66, \"de_ratio\": 0.0, \"current_ratio\": 9.58, \"operating_cf\": -140534000.0, \"operating_cf_fmt\": \"-\u00a51\u5104\", \"investing_cf\": -1087496000.0, \"investing_cf_fmt\": \"-\u00a511\u5104\", \"financing_cf\": 482872000.0, \"financing_cf_fmt\": \"\u00a55\u5104\", \"free_cf\": -301566000.0, \"free_cf_fmt\": \"-\u00a53\u5104\", \"net_margin\": -10.34, \"roe\": -4.03, \"roa\": -3.65}, {\"year\": 2022, \"revenue\": 0, \"revenue_fmt\": \"N\/A\", \"gross_profit\": 0, \"gross_profit_fmt\": \"N\/A\", \"operating_income\": 0, \"operating_income_fmt\": \"N\/A\", \"ebit\": 0, \"ebit_fmt\": \"N\/A\", \"net_income\": 0, \"net_income_fmt\": \"N\/A\", \"eps\": 0, \"operating_margin\": 0, \"total_assets\": 0, \"total_assets_fmt\": \"N\/A\", \"total_equity\": 0, \"total_equity_fmt\": \"N\/A\", \"total_debt\": 80000000.0, \"total_debt_fmt\": \"\u00a580.0M\", \"total_cash\": 0, \"total_cash_fmt\": \"N\/A\", \"equity_ratio\": 0, \"de_ratio\": 0, \"current_ratio\": 0, \"operating_cf\": 0, \"operating_cf_fmt\": \"N\/A\", \"investing_cf\": 0, \"investing_cf_fmt\": \"N\/A\", \"financing_cf\": 0, \"financing_cf_fmt\": \"N\/A\", \"free_cf\": 0, \"free_cf_fmt\": \"N\/A\", \"net_margin\": 0, \"roe\": 0, \"roa\": 0}], \"has_data\": true}, \"dividends\": {\"history\": [], \"has_data\": false}}","ma_5_value":0,"ma_5_deviation":0,"ma_5_trend":"","ma_25_value":0,"ma_25_deviation":0,"ma_25_trend":"","ma_75_value":0,"ma_75_deviation":0,"ma_75_trend":"","ma_200_value":0,"ma_200_deviation":0,"ma_200_trend":"","previousClose":0,"open":0,"dayHigh":0,"dayLow":0,"volume":0,"averageVolume":0,"revenueGrowth":0},"sector":[],"class_list":["post-58459","company","type-company","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>REPROCELL INCORPORATED - Japan IR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/japanir.jp\/en\/company\/company-4978\/\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4978\/\",\"url\":\"https:\/\/japanir.jp\/en\/company\/company-4978\/\",\"name\":\"REPROCELL INCORPORATED - Japan IR\",\"isPartOf\":{\"@id\":\"https:\/\/japanir.jp\/en\/#website\"},\"datePublished\":\"2026-06-04T13:04:32+00:00\",\"dateModified\":\"2026-08-16T05:02:10+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4978\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/japanir.jp\/en\/company\/company-4978\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/japanir.jp\/en\/company\/company-4978\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/japanir.jp\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"REPROCELL INCORPORATED\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/japanir.jp\/en\/#website\",\"url\":\"https:\/\/japanir.jp\/en\/\",\"name\":\"Japan IR\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/japanir.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"REPROCELL INCORPORATED - Japan IR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/japanir.jp\/en\/company\/company-4978\/","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/japanir.jp\/en\/company\/company-4978\/","url":"https:\/\/japanir.jp\/en\/company\/company-4978\/","name":"REPROCELL INCORPORATED - Japan IR","isPartOf":{"@id":"https:\/\/japanir.jp\/en\/#website"},"datePublished":"2026-06-04T13:04:32+00:00","dateModified":"2026-08-16T05:02:10+00:00","breadcrumb":{"@id":"https:\/\/japanir.jp\/en\/company\/company-4978\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/japanir.jp\/en\/company\/company-4978\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/japanir.jp\/en\/company\/company-4978\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/japanir.jp\/en\/"},{"@type":"ListItem","position":2,"name":"REPROCELL INCORPORATED"}]},{"@type":"WebSite","@id":"https:\/\/japanir.jp\/en\/#website","url":"https:\/\/japanir.jp\/en\/","name":"Japan IR","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/japanir.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company\/58459","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/company"}],"about":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/types\/company"}],"wp:attachment":[{"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/media?parent=58459"}],"wp:term":[{"taxonomy":"sector","embeddable":true,"href":"https:\/\/japanir.jp\/en\/wp-json\/wp\/v2\/sector?post=58459"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}